Relay Therapeutics
Drug Discovery · Biotechnology

Relay Therapeutics: Ownership & structure

Relay Therapeutics operates through 1 legal entity in 1 country.

Data updated Nov 22, 2026 · Back to the company report

Owners & entities

Relay Therapeutics operates through 1 legal entity in 1 country.

Legal entities1 in 1 country
Relay Therapeutics, Inc.
operator
US
Subsidiaries in its annual report: 1 in 1 jurisdictions · Massachusetts 1 · sec.gov ↗
Large holders (13D / 13G)holders of 5% or more, their newest filing
T. Rowe Price Investment Management, Inc.
passive holder · SCHEDULE 13G · Nov 2026
SB INVESTMENT ADVISERS (UK) LTD
passive holder · SCHEDULE 13G/A · Nov 2026
Commodore Capital LP
passive holder · SCHEDULE 13G/A · Aug 2026
PERCEPTIVE ADVISORS LLC
passive holder · SCHEDULE 13G/A · Aug 2026
FMR LLC
passive holder · SCHEDULE 13G/A · Aug 2026
Point72 Asset Management, L.P.
passive holder · SCHEDULE 13G/A · May 2026
VANGUARD GROUP INC
passive holder · SCHEDULE 13G/A · Mar 2026
Casdin Capital, LLC
passive holder · SCHEDULE 13G/A · Feb 2026
BlackRock, Inc.
passive holder · SCHEDULE 13G/A · Apr 2025
Insider tradesopen-market buys and sales on SEC Form 4, last 12 months

Insiders bought $0 (0 people) and sold $127.9M (5 people) in the last 12 months.

Sold · President and CEO
48,199 shares at $18.94 · Sep 2026
$913k
Sold · Chief Financial Officer
17,717 shares at $18.94 · Sep 2026
$336k
Sold · President, R&D
8,530 shares at $18.97 · Sep 2026
$162k
Sold · See remarks
4,508 shares at $20.03 · Aug 2026
$90k
Sold · SB INVESTMENT ADVISERS (UK) LTD · Ten Percent Owner
6,000,000 shares at $19.40 · Aug 2026
$116.4M
Sold · President and CEO
48,199 shares at $20.33 · Aug 2026
$980k
Sold · Chief Financial Officer
17,717 shares at $19.74 · Aug 2026
$350k
Sold · President, R&D
2,237 shares at $18.61 · Jul 2026
$42k
Sold · Chief Financial Officer
1,459 shares at $18.61 · Jul 2026
$27k
Sold · See remarks
748 shares at $18.61 · Jul 2026
$14k
Holders and shares as each register or filing states them.

Connections

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors3
Nextech InvestVia a fund
63 portfolio companies: Zymeworks, Vividion Therapeutics (Acquired), Zenith Therapeutics and 60 more
EcoR1 CapitalVia a fund
69 portfolio companies: Unity Biotechnology, Terremoto Bio, zapprx.com and 66 more
GVVia a fund
572 portfolio companies